Prescription characteristics of the insulin glargine plus lixisenatide fixed-ratio combination in real-world clinical practice according to the Registry of Diabetes Mellitus in the Moscow Region
Background: An individualized approach to the treatment of type 2 diabetes mellitus (T2DM) in real-world clinical practice involves identification of patients groups with a maximal response to a certain type of therapeutic intervention. The assessment of clinical characteristics of T2DM patients sel...
Saved in:
| Main Authors: | Inna V. Misnikova, Yulia A. Kovaleva, Margarita A. Andropova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
MONIKI
2024-12-01
|
| Series: | Alʹmanah Kliničeskoj Mediciny |
| Subjects: | |
| Online Access: | https://almclinmed.ru/jour/article/viewFile/17291/1722 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real World Effectiveness of fixed combination of glargine 100 U/ml and lixisenatide therapy in outpatients with Type 2 Diabetes: A Retrospective Cohort Study SOLO
by: M. B. Antsiferov, et al.
Published: (2022-05-01) -
Real-world effectiveness and safety of fixed-ratio combination insulin glargine 100 u/ml plus lixisenatide in adults with type 2 diabetes (T2DM): subanalysis of the international, multicentre, prospective observational study SUCCESS in the Russian population
by: O. K. Vikulova, et al.
Published: (2024-11-01) -
On the safety of insulin Glargine
by: Ivan Ivanovich Dedov, et al.
Published: (2009-09-01) -
Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
by: Ivona Renata Yarek-Martynova, et al.
Published: (2011-12-01) -
Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study
by: Elena Valer'evna Biryukova, et al.
Published: (2012-09-01)